BC
BMO Capital Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
801
Arvinas
ARVN
$575M
|
ML
Matthew Luchini
| $7.83 | $101 |
1,190%
upside
| Outperform | 4 years ago |
|
802
Ionis Pharmaceuticals
IONS
$9.76B
|
DK
Do Kim
| $61.23 | $76 |
24%
upside
| Outperform | 4 years ago |
|
803
Nuvation Bio
NUVB
$1.33B
|
DK
Do Kim
| $3.90 | $16 |
310%
upside
| Outperform | 4 years ago |
|
804
AGCO
AGCO
$8.28B
|
JT
Joel Tiss
| $111.02 | $200 |
80%
upside
| Outperform | 4 years ago |
|
805
Amcor
AMCR
$19.1B
|
MW
Mark Wilde
| $8.30 | $13 |
57%
upside
| Outperform | 4 years ago |
|
806
Vertex Pharmaceuticals
VRTX
$102B
|
DK
Do Kim
| $396.12 | $284 |
28%
downside
| Outperform | 4 years ago |
|
807
Alnylam Pharmaceuticals
ALNY
$59.2B
|
DK
Do Kim
| $452 | $185 |
59%
downside
| Market Perform | 4 years ago |
|
808
Regeneron Pharmaceuticals
REGN
$60.8B
|
ML
Matthew Luchini
| $573.38 | $630 |
10%
upside
| Outperform | 4 years ago |
|
809
Andersons Inc
ANDE
$1.42B
|
KZ
Kenneth Zaslow
| $41.40 | $26 |
37%
downside
| Market Perform | 4 years ago |
|
810
Welltower
WELL
$112B
|
JK
John Kim
| $167.82 | $64 |
62%
downside
| Underperform | 4 years ago |
|
811
AbCellera Biologics
ABCL
$1.26B
|
DK
Do Kim
| $4.22 | $48 |
1,037%
upside
| Outperform | 4 years ago |
|
812
fuboTV
FUBO
$1.37B
|
DS
Daniel Salmon
| $4.01 | $50 |
1,147%
upside
| Market Perform | 4 years ago |
|
813
Alliant Energy
LNT
$16.6B
| $64.62 | $54 |
16%
downside
| Market Perform | 4 years ago |
|
|
|
ACB
814
Aurora Cannabis
ACB
$276M
|
TC
Tamy Chen
| $4.91 | $9 |
83%
upside
| Underperform | 4 years ago |
|
815
Cross Country Healthcare
CCRN
$462M
|
JS
Jeffrey Silber
| $14.10 | $10 |
29%
downside
| Outperform | 4 years ago |
|
816
Moderna
MRNA
$9.78B
|
GF
George Farmer
| $25.14 | $109 |
334%
upside
| Market Perform | 4 years ago |
|
817
Teradata
TDC
$1.99B
|
KB
Keith Bachman
| $21.01 | $22 |
5%
upside
| Market Perform | 4 years ago |
|
818
Teva Pharmaceuticals
TEVA
$21.7B
| $18.95 | $11 |
42%
downside
| Market Perform | 4 years ago |
|
|
819
Incyte
INCY
$16.9B
|
GF
George Farmer
| $86.64 | $87 |
0%
upside
| Market Perform | 4 years ago |
|
820
Yelp
YELP
$2.02B
|
DS
Daniel Salmon
| $32 | $27 |
16%
downside
| Market Perform | 4 years ago |
|
821
Corteva
CTVA
$49.1B
| $72.30 | $38 |
47%
downside
| Outperform | 4 years ago |
|
|
822
GFL Environmental
GFL
$17.4B
| $47.90 | $26 |
46%
downside
| Outperform | 4 years ago |
|
|
823
Madrigal Pharmaceuticals
MDGL
$9.65B
|
ML
Matthew Luchini
| $432.89 | $124 |
71%
downside
| Market Perform | 4 years ago |
|
824
IAMGOLD
IAG
$5.7B
| $9.91 | $5.50 |
45%
downside
| Market Perform | 4 years ago |
|
|
825
GeoPark
GPRK
$326M
|
MM
Mike Murphy
| $6.33 | $10 |
58%
upside
| Market Perform | 4 years ago |
|